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A B S T R A C T
Objective: Knowledge about the etiology of community-acquired pneumonia (CAP) is essential for
adequate management. Presently, few studies about CAP are available from Southeast Asia. This study
aimed to investigate the etiology, severity, and outcome of CAP in the most populous Southeast Asia
country, Indonesia.
Methods: From October 2007 to April 2009, adult patients admitted with CAP to two hospitals in
Semarang, Indonesia, were included to detect the etiology of CAP using a full range of diagnostic
methods. The severity of disease was classiﬁed according to the Pneumonia Severity Index (PSI). The
outcome was assessed as 30-day mortality.
Results: In total, 148 consecutive patients with CAP were included. Inﬂuenza virus (18%), Klebsiella
pneumoniae (14%), and Streptococcus pneumoniae (13%) were the most common agents identiﬁed. Other
Gram-negative bacilli, Mycobacterium tuberculosis, Chlamydia pneumoniae each accounted for 5%. The
bacteria presented wild type antibiotic susceptibility proﬁles. Forty-four percent of subjects were high-
risk patients (PSI class IV-V). The mortality rate (30%) was signiﬁcantly associated with disease severity
score (P<0.001), and with failure to establish an etiological diagnosis (P=0.027). No associations were
found between etiology and underlying diseases, PSI class, nor mortality.
Conclusions: Viruses and Gram-negative bacilli are dominant causes of CAP in this region, more so than S.
pneumoniae. Most of the bacteria have wild type susceptibility to antimicrobial agents. Patients with
severe disease and those with unknown etiology have a higher mortality risk.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Knowledge about the etiology of community-acquired pneumo-
nia (CAP) is essential for patient management.1 However, only few
studies on CAP are available from Southeast Asia. Many countries in
Southeast Asia have no published or peer reviewed studies on CAP,
including Indonesia, Brunei, Myanmar, Cambodia, East Timor, Laos,
Vietnam, and most published studies used limited or unstandard-
ized microbiological methods.2–5 The etiology of CAP has been
reported to differ in different geography and demography settings,* Corresponding author.
E-mail address: helmia_farida@yahoo.com (H. Farida).
http://dx.doi.org/10.1016/j.ijid.2015.07.023
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).thus, the management should not directly be adopted from other
countries. Local data should be provided using a systematic and
standardized method. This study aimed to describe the current
etiology of CAP using a full range of diagnostic methods.
Antimicrobial susceptibility of bacterial pathogens, underlying
diseases, severity and outcome of these CAP patients were analyzed.
2. Materials and Methods
2.1. Study design
A prospective cohort study was performed in Dr. Kariadi
Hospital (an 850-bed academic hospital) and in Semarang
Municipal Hospital (a 130-bed secondary hospital).ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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From October 2007 until April 2009 hospitalised patients >13
years were included if CAP was diagnosed within 24 hours of
admission. CAP was deﬁned as radiological evidence of an inﬁltrate
on chest X-ray and 2 of 6 criteria (cough, purulent sputum,
temperature >38.50C, abnormal chest auscultation, white blood
cell count >10 or <4 109/l, positive culture of blood or pleural
ﬂuid). Subjects were excluded if they had received parenteral
antibiotic before inclusion, had been hospitalised within four
weeks of admission, were severely immunocompromised (HIV
infection, chemotherapy, neutropenia <1000/uL, steroid treat-
ment >20 mg/day for more than two weeks), had terminal stage of
malignancy, or evidence of other causes of abnormalities on the X-
ray.
2.3. Data collection
All patients were assessed upon admission, followed up daily
during hospitalisation, and on day-30 according to a standardised
protocol. Age, gender, cigarette and alcohol use, and clinical
presentations were recorded. The admission chest X-rays were
assessed by a radiologist in-charge, and later re-assessed to
develop standardised X-ray descriptions. Complete blood cell-
count, blood chemistry, and blood-gas analysis were performed on
admission. Underlying diseases were assessed from clinical,
laboratory and radiology data. Severity score was determined
using the Pneumonia Severity Index (PSI).6 The outcome was
assessed as 30-day mortality. Management of patients was left to
the discretion of the physicians in charge.
2.4. The microbiological evaluation
Sputum, throat swab, blood, paired sera with a 4-week
interval, and urine were sent to the Clinical Microbiology
Laboratory of Dr. Kariadi Hospital, Semarang. Gram-stained
smears were evaluated to assess sputum quality and to help
culture interpretation. Ziehl–Neelsen staining was done to screen
for acid fast bacilli. Blood was cultured by inoculating four
BACTEC bottles [Becton-Dickinson, Rochester, UK] per patient,
and sputum samples were inoculated on blood agar, chocolate
agar, chocolate agar with gentamicin 5 mg/L, and MacConkey
agar (Oxoid, Basingstoke, UK). Crystal violet colistin broth (CVCB)
and Ashdown agar7 were used for Burkholderia pseudomallei
isolation. Bacteria isolated from the initial cultures, sputa, throat
swabs, sera, and urine were stored at -80oC, and transported to
Rotterdam, for further analyses.
Streptococcus pneumoniae was identiﬁed with optochin disk
(Oxoid) and, in case of doubt, DNA probe (Accuprobe, San Diego,
USA). Gram-negative bacilli (GNB) were identiﬁed using the
Vitek-2 system (bioMe´rieux, l’Etoile, France). Acinetobacter
baumannii was identiﬁed using PCR (blaOXA-51-like).
8 Moraxella
catarrhalis was conﬁrmed using tributyrin test (Rosco Diagnos-
tics-Taastrup, Denmark). X-V factors (Becton, Dickinson and
Company - Sparks, USA) were used for Haemophilus inﬂuenzae
identiﬁcation. Slidex Staph Plus latex agglutination (bioMe´rieux)
and Vitek-2 were used for Staphylococcus aureus identiﬁcation.
Ziehl-Neelsen positive sputa were cultured on MGIT media
(Becton-Dickinson, Rochester, UK) and conﬁrmed by PCR.
Antimicrobial susceptibility tests were performed with disk
diffusions (for S. pneumoniae), Vitek-2 (for S. aureus and GNB),
and E-test (for M. catarrhalis). When extended-spectrum b-
lactamase (ESBL)-production was suspected, isolates were further
analyzed with cefotaxime-clavulanate or ceftazidime-clavula-
nate E-test (bioMe´rieux). Reference strains from ATCC were used
as controls and CLSI guidelines were applied.Serology tests were performed with ELISA for Chlamydia
pneumoniae (Medac Diagnostika, Germany), Mycoplasma pneumo-
niae (Virion\Serion, Wu¨rzburg, Germany), and Legionella pneumo-
phila (Wampole Laboratories, Princeton, USA). Leptospira serology
was performed using microscopic agglutination test (MAT) and
ELISA9 in the Royal Tropical Institute (KIT), Amsterdam, the
Netherlands, if the patient had a clinical syndrome compatible
with leptospirosis. ELISA for respiratory viruses (Virion\Serion)
was performed in the Laboratory of Viroscience, Erasmus MC. Real-
time PCRs (RT-PCRs) were done on sputum and on throat swabs for
C. pneumoniae and L. pneumophila as described elsewhere.10 RT-
PCR for M. pneumoniae, rhinovirus, human corona virus (HcoV)
229E, OC43, and NL63, inﬂuenza A and B virus, human
metapneumovirus (hMPV), RSV A and B, parainﬂuenza 1- 4 virus,
adenovirus, and bocavirus were performed on throat swabs.
Validation of PCR procedures11,12 and PCR for Leptospira and for
Chlamydia psittaci13,14 were done as described elsewhere. PCR for
Mycobacterium tuberculosis was performed in Erasmus MC. Urinary
antigen tests (BinaxNOW, Portland, USA) were performed to detect
S. pneumoniae and L. pneumophila serogroup-1 antigen.
2.5. Diagnostic criteria for microbial etiological agents
Sputum cultures were considered positive if sputum quality
was good (leukocytes: epithelial-cells ratio was >2.5: 1, leukocyte
count was >10/low power ﬁeld (LPF), epithelial-cell count was
<10/LPF), and bacteria growing predominantly on agar were
compatible with sputum microscopy. Blood cultures were
considered positive if bacteria presented in 1 bottle for
established pathogens or 2 bottles for other species.
Serology was considered positive if there was a four-fold titer
increase of any immunoglobulin class. For inﬂuenza A and B,
since re-infection in one year is unlikely, single sera with
positive IgA and negative IgG during the ﬁrst week of illness
were also considered positive. Immunoglobulin classes mea-
sured were IgM, IgA, and IgG for C. pneumoniae; total
immunoglobulin for L. pneumophila; IgA and IgG for respiratory
viruses; IgM and IgG for M. pneumoniae; IgM and total
immunogloblin for Leptospira.
RT-PCR were considered positive if the CT value was <50 for M.
pneumoniae, 35 for Leptospira, and <40 for other pathogens. A
positive inﬂuenza A PCR was followed with another PCR to
distinguish H5N1 from other inﬂuenza A viruses. Any visible
reaction of the urinary antigen tests was considered positive as
instructed by the manufacturer.
For each patient a comprehensive review of the clinical,
radiological, and laboratory data was performed by a panel
involving a pulmonologist, infectious disease specialists, radiolo-
gists, and clinical microbiologists to draw the ﬁnal conclusions on
the etiology of CAP. Etiology was considered established if
microbiology test results were compatible with the clinical
presentation and radiology.
2.6. Statistical analysis
Chi-Square or Fisher’s exact test where appropriate was
performed using SPSS 17 (SPSS Inc., Chicago, USA). The Kaplan-
Meier method and the log-rank test were used to perform survival
analysis. P value of <0.05 was considered signiﬁcant.
2.7. Ethics
The study was approved by The Ethical Committee of
Faculty of Medicine Diponegoro University- Dr. Kariadi Hospital
(36EC/FK/RSDK/2007). A written informed consent was obtained
from each patient or guardian.
Table 1
Characteristics of patients with community-acquired pneumonia in Semarang,
Indonesia
Characteristic Number of Patients
(Total N = 148)
Age years, median; Inter quartile range (IQR) 58 (45-69)
Male/female 73 / 75
Length of stay, median (IQR) days 6 (4-8)
30-day mortality (%) 44 (30)
Underlying diseases (%)
Hypertension 25 (17)
Congestive heart disease 16 (11)
Diabetes mellitus 14 (10)
Chronic obstructive pulmonary disease 12 (8)
Stroke 27 (18)
Asthma 3 (2)
Malignancy 5 (3)
Chronic kidney disease 4 (3)
Pneumonia Severity Index/ PSI (%)*
Class I 6 (4)
Class II 45 (30)
Class III 32 (22)
Class IV 45 (30)
Class V 20 (14)
Chest X-ray (%)
Bronchopneumonia 103 (70)
Alveolar pneumonia 32 (21)
Interstitial pneumonia 13 (9)
Specimens obtained (%)
Sputum, total/good quality** 103 (70) / 57 (39)
Blood culture 148 (100)
Paired sera/single sera 83 (56) / 64 (43)
Throat swabs 148 (100)
Urine 145 (98)
* according to Fine et al., 19976.
** sputum was considered of good quality if the leukocytes: epithelial cells ratio
was >2.5, and the leukocyte count was 10/LPF and the epithelial cell count <10/
LPF.
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3.1. Patient characteristics
Of the 156 patients enrolled; 135 were hospitalised in Dr.
Kariadi hospital and 21 in Semarang Municipal hospital. Eight
patients were excluded because of non-conﬁrmed CAP diagnosis
(acute respiratory distress syndrome (3 patients), urosepsis
(2 patients), no inﬁltrate on the X-ray on re-assessment
(2 patients)), or preceding parenteral antibiotics (1 patient)).
Patients’ ages ranged 14–88 years, with 32% aged >60 years. Most
patients (52%) had underlying diseases, with 19% having two or
more underlying diseases. Severe pneumonia (PSI IV-V) was found
in 44% patients. Most (70%) of the chest X-rays showed
bronchopneumonia (Table 1).
Only 15% of patients had not received oral antibiotics prior to
hospital admission, while 50% were unsure whether they had
received antibiotics or not. Thirty eight (26%) patients had a
complete set of test specimens (Table 1). No data were missing for
underlying diseases, severity, and 30-day mortality.
3.2. Microbiological results
One-hundred and ﬁfty respiratory pathogens were identiﬁed
from 100 (68%) patients. The microbiological methods by which
pathogens were identiﬁed are described in Table 2. Final conclu-
sions regarding the CAP etiology are summarised in Tables 3 and 4.
A single causative agent was found in 58 (39%) patients, of
which 33 (22%) were viruses and 25 (17%) were bacteria.
Polymicrobial infection was found in 42 (28%) patients, including
viral infections with superimposed bacterial infection, tuberculosis
with superimposed secondary infection, and other mixed-infec-
tions (multiple viruses, multiple bacteria, and combinations of
virus(es) and bacteria) (Table 3).
Seventy viruses were identiﬁed in 67 (45%) patients, with
inﬂuenza A as commonest, identiﬁed in 20 (13.5%) patients. PCR
detected 16 (80%) cases, while serology detected 10 (50%) cases
(Table 2). All inﬂuenza A viruses were H3N2. In 12 patients it wasTable 2
Pathogens isolated from laboratory specimens obtained from patients with community
Pathogens Blood
Culture
Sputum
Culture
Urinary
Antigen
Test
Blood and
Sputum
Culture
Sputum
Culture +
UAT
Viruses
Inﬂuenza A virus 
Inﬂuenza B virus 
Rhinovirus 
PIV 1-4 
HcoV OC43 
Adenovirus 
hMPV 
RSV 
Total Viruses 
Bacteria
S. pneumoniae 1 15 3 
S. aureus 3 1 
K. pneumoniae 20 1 
Other GNB 1 6 
M. catarrhalis 5 
C. pneumoniae 
M. pneumoniae 
L. pneumophila 1 
M. tuberculosis 1 
Leptospira 
Total bacteria 1 36 16 2 3 
Total pathogens 
UAT = urinary antigen test, PIV = parainﬂuenza virus, HcoV = human coronavirus, hMPV
Other GNB = Other Gram-negative bacilli, i.e. E. cloacae, S. maltophilia, A. xylosoxidans, the single pathogen found (Table 3); in eight patients other
pathogens were also involved (Table 4). Together, inﬂuenza A and
B viruses caused 26 (18%) cases of CAP in our cohort either as single
or as co-pathogen.-acquired pneumonia in Semarang, Indonesia
Blood and
Sputum
Culture + UAT
Serology PCR Serology +
PCR
Culture +
PCR
Total
4 10 6 20
2 4 6
13 13
2 9 11
8 8
2 4 6
4 4
1 1 2
11 53 6 70
1 20
4
21
7
5
8 8
1 1
1
7 8
1 2 2 5
1 9 3 2 7 80
150
 = human metapneumovirus, RSV = respiratory syncytial virus.
B. cepacia.
Table 3
Final etiological diagnosis in patients presenting with community-acquired
pneumonia in Semarang, Indonesia
Etiology Patients (N = 148)
Number (%)
Single pathogen 58 (39)
virus
Inﬂuenza A/B virus 12 (8) / 5 (3)
Rhinovirus 6 (4)
Parainﬂuenza virus 5 (3)
Adenovirus 2 (1)
Respiratory Syncytial virus 1 (1)
Coronavirus OC43 1 (1)
human Metapneumovirus 1 (1)
Subtotal 33 (22)
bacteria
K. pneumoniae 5 (3)
S. pneumoniae 5 (3)
M. tuberculosis 5 (3)
Leptospira spp 4 (3)
C. pneumoniae 2 (1)
S. aureus 2 (1)
M. catarrhalis 1 (1)
B. cepacia 1 (1)
Subtotal 25 (17)
More than one pathogen*
Viral infection with superimposed bacterial infection 24 (16)
Tuberculosis with superimposed infection 3 (2)
Other mixed infections 15 (10)
Subtotal 42 (28)
Unknown etiology (no pathogen detected) 48 (32)
* for further details, see Table 4.
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(9%) cases were detected by PCR. In six patients this virus was the
single pathogen; in seven it was a co-pathogen. Parainﬂuenza virus
was the third commonest virus, detected in 11 (7%) patients,
mostly by PCR; ﬁve episodes as single pathogen and six as co-
pathogen. Other viruses found were HcoV OC43, adenovirus,
hMPV, and RSV; most were as co-pathogens, and detected by PCR.
Eighty bacteria were found in 65 (44%) patients, with Klebsiella
pneumoniae and S. pneumoniae as the most frequently diagnosed. K.Figure 1. Survival of patients with Community-acquired pneumonia according to
diagnostic yield
. . .. . .. . .. Patients with more than one pathogen
—————— Patients with single pathogen
_. . _. . Patients with no pathogen detectedpneumoniae was isolated from 21 (14%) patients; most (95%) from
sputum cultures, and 5% from both blood and sputum cultures. S.
pneumoniae was diagnosed in 20 (13%) patients, mostly (75%) by
urinary antigen tests (Table 2). C. pneumoniae and M. tuberculosis
were the third commonest bacterial species identiﬁed; each was
diagnosed in 5% of patients. Other GNB (Enterobacter cloacae,
Klebsiella oxytoca, Achromobacter xylosoxidans, and Burkholderia
cepacia) were identiﬁed in 7 (5%) patients; most were isolated from
sputum cultures. Burkholderia pseudomallei was not found. Blood
cultures were positive only in 4 (2%) patients.
Combinations of pathogens in 42 patients are presented in
Table 4. Frequent combinations of pathogens were K. pneumo-
niae + S. pneumoniae (n=5), adenovirus + K. pneumoniae (n=4), and
inﬂuenza or coronavirus + S. pneumoniae (n=3 each).
The etiology of CAP could not be elucidated in 48 (32%) patients.
Pathogen detection was, predictably, related to the availability of
diagnostic specimens. Out of 48 cases with unknown etiology, only
one patient had complete laboratory specimens from which all
tests results were negative. The other 47 had incomplete
laboratory specimens; 46 of them had no positive results, and
one had so many positive serology results that no conclusion could
be drawn. Patients with severe disease (PSI class IV–V) were less
likely to receive an etiological diagnosis compared to those with
non-severe disease (PSI class I-III, P=0.01).
One isolate of K. pneumoniae was an ESBL-producer, while the
others were susceptible to antibiotics except to piperacillin (81%
resistant) and nitrofurantoin (76% resistant). Of four regrowable S.
pneumoniae, all were susceptible to penicillin, erythromycin, and
vancomycin; one was intermediately resistant to co-trimoxazol,
and three were resistant to tetracyclin.
3.3. Clinical outcome
There was no signiﬁcant difference in underlying diseases, PSI
class, length of stay, and mortality among patients with single viral,
single bacterial, and mixed viral-bacterial infections (P>0.05).
Patients with mixed-viral and mixed-bacterial infections were not
analysed due to small numbers. The overall 30-day mortality rate
was high (30%) and signiﬁcantly associated with severity of disease
(P<0.001). The mortality rate ranged from 17% in PSI class I
patients to 80% in PSI class V patients. Interestingly, survival
analysis showed a signiﬁcantly lower survival rate in CAP patients
with unknown etiology (Figure 1). Early death (48 hours of
hospitalization) happened in 18 patients (41% mortality), and was
associated with respiratory failure or irreversible septic shock;
most of the early deceased patients (14 subjects) had delayed or no
access to ICU care because of limited availability of the service. Late
death (>48 hours of hospitalization) occurred in 14 patients (32%
of mortality), and was associated with worsening conditions from
CAP (7 patients) or with their underlying diseases (7 patients).
Despite clinical improvement, 12 patients (27% of mortality) died
after discharge from hospital for in-home recovery within 30 days
of admission. The circumstance of these latter death remained
unknown.
4. Discussion
This is the ﬁrst CAP etiology study conducted in Indonesia
applying a full range of microbiology tests. Inﬂuenza viruses, K.
pneumoniae, and S. pneumoniae were the commonest agents of CAP
in this region of the world.
Viral infections were surprisingly common, either as single or
combined etiology. PCR was instrumental in detecting most
respiratory viruses. A recent report from Thailand found viruses
in 9% of hospitalised adult CAP patients in Northern Thailand2 and
in 25% of adult CAP patients admitted from a pneumonia
Table 4
Combinations of respiratory pathogens observed among patients with community-acquired pneumonia
PIV = parainﬂuenza virus.
Note: 42 patients with multiple infection, of which 35 had two pathogens, 6 had three pathogens
(Rhinovirus + S. pneumoniae + S. aureus, Adenovirus + K. pneumoniae + S. pneumoniae, Adenovirus + K.
pneumoniae + other GNB*, Coronavirus + K. pneumoniae + M. catarrhalis, RSV type A + K. pneumoniae + S.
pneumoniae, Parainﬂuenza + K. pneumoniae + S. pneumoniae) and one patient had 4 pathogens (Coronavir-
us + h-Metapneumovirus + K. oxytoca + M. catarrhalis).
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infection was 7.4% in hospitalised CAP15 and 7% in severe CAP.5 The
use of PCR may, thus, enhance the appropriate use of antimicrobial
agents.16 No other CAP studies in Southeast Asia so far have
attempted to diagnose viruses.
K. pneumoniae and other GNB were frequently observed in our
study, similar to reports from other Southeast Asian countries,2,3,17
but different from those from Europe, North America, or
Australia.1,18,19 The high prevalence of K. pneumoniae and other
GNB might, in part, be explained by the common carriage of these
bacterial species in the nasopharynx of healthy individuals in the
same area.20 The tropical climate with higher temperature and
humidity in Semarang may increase the incidence of GNB infection,
as those conditions promote the growth and virulence of GNB.21,22
S. pneumoniae infection was detected in only 13% of the
patients, mostly by urinary antigen tests. Cultures frequently failed
to grow this species, possibly due to the common use of antibiotics
in the community, underlining the importance of alternative
methods to detect pneumococci, as by PCR3 or urinary antigen
test.23 However, a positive ﬁnding with the latter test should be
interpreted carefully particularly in patients with COPD.23 Previ-
ous studies in Southeast Asia reported various numbers for the
relative contribution of S. pneumoniae, from 2%17 through 52%24
depending on the study population and the laboratory methods,
while studies from Europe, North America, and Australia
consistently reported it as the most common cause of CAP.1,18,19Aside from the climate, the differences between the CAP
etiology reported in our study and that in previous reports might
also relate to differences in patients age, underlying diseases, and
radiological type of pneumonia. Our patients were relatively
young, had more often cerebrovascular underlying diseases, and
had often bronchopneumonia instead of lobar or alveolar
pneumonia. The wide spread use of inﬂuenza vaccination in other
parts of the world may help explain the differences in the incidence
of inﬂuenza in CAP. Taken together, these differences imply that a
guideline of CAP management construed and implemented in
Europe, North America, and Australia might not be directly
applicable in Indonesia.
Most CAP studies distinguished deﬁnite from probable etiology
based on microbiology results. We did not use this distinction,
instead, we interpreted microbiological, clinical and radiological
ﬁndings in a multidisciplinary discussion to make a ﬁnal diagnosis,
since in our opinion, clinical data cannot be omitted in doing so.
Extending the range of laboratory diagnostics applied to include
viral as well as bacterial and fungal pathogen will, predictably
increase the number of pathogens detected, and, thereby, increase
the chance of ﬁnding polymicrobial infections.4,25We found mixed
infection in a sizable proportion of the cohort of patients included
in the study. Some of these mixed infections are common, e.g. viral
infection with superimposed bacterial infection26 and tuberculosis
with superimposed infection. Other mixed infections, e.g. by
multiple bacteria or multiple viruses, are more difﬁcult to
H. Farida et al. / International Journal of Infectious Diseases 38 (2015) 101–107106understand and pose the problem of discriminating between
infection and carriage.
Most bacteria causing CAP in our study were susceptible to
early generation antibiotics. These ﬁndings are consistent with
other observation from Indonesia.27,28 Hence, the choice of
antibiotics for the initial empirical treatment of CAP should not
include the later generation of antibiotics, including a third
generation cephalosporin which is recommended by the local
guideline.29 A more appropriate choice to consider would be
amoxicillin-clavulanic acid or ampicillin-sulbactam.
The crude mortality rate was high, and related to severity of the
disease. However, even in low risk patients, the mortality in our
study was still quite high, not only compared to that in North-
America and Europe, but also to other studies from Southeast Asian
countries.2,5 The high mortality observed in our study suggests
problems in the patient care process, which needs further analysis.
Determinants of poor outcome may at least in part, include delay in
presenting to the hospital, inappropriate initial treatment, limited
access to mechanical ventilators, inappropriate antibiotic therapy,
underlying diseases, and the severity of the disease on admission
(to be published elsewhere). Interestingly, mortality was signiﬁ-
cantly higher among patients with unknown etiology. This ﬁnding
may be explained by limitations in acquiring appropriate
laboratory samples due to the severity of the disease at the time
the patients were admitted. This is rather unfortunate, since these
patients are those who need most to be managed based on an
established etiology. This ﬁnding implies the need to perform all
diagnostic procedures early, without delay, especially in patients
with severe disease, so that the etiology of CAP in this group is
established early, at a time its management can still be optimised.
Since this study was performed in one urban area in Indonesia,
involving only two hospitals, our ﬁndings might not be representa-
tive for the whole of Indonesia. A similar, multicenter study of the
etiology of CAP in Indonesia would be needed to conﬁrm the peculiar
spectrum of etiology of CAP in Indonesia suggested by this study.
5. Conclusions
Multicenter CAP studies which include viral etiologies, should
be carried out in Indonesia and other countries in this region to
delineate the full spectrum of etiological agents in CAP patients
and to generate local guidelines for the management of CAP.
Bacteria causing CAP in this area of the world continue to
present wild type antibiotic susceptibility proﬁles so that early
generation antibiotics can be used as initial empiric treatment,
thereby avoiding the expense and selection pressure exerted by
newer generations of antibiotics, especially third generation
cephalosporins and carbapenems. The frequent incidence of
GNB infection requires initial therapy to cover GNB in addition
to the Pneumococcus. Rapid bacteriological diagnostics are
required to be able to adapt initial therapy, including alternative
tests for detecting S. pneumoniae. Performing diagnostic proce-
dures early, without delay, should be prioritized since establishing
an etiological diagnosis is likely to improve clinical outcomes.
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